A5044507624- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Cardiac, Anesthesia and Surgical Outcomes
- Organ Transplantation Techniques and Outcomes
- COVID-19 and healthcare impacts
- Respiratory Support and Mechanisms
- Intensive Care Unit Cognitive Disorders
- COVID-19 Clinical Research Studies
- Transplantation: Methods and Outcomes
- Long-Term Effects of COVID-19
- Disaster Response and Management
- Ultrasound in Clinical Applications
- Airway Management and Intubation Techniques
- Liver Disease and Transplantation
- Medical History and Innovations
- Heparin-Induced Thrombocytopenia and Thrombosis
- Cardiovascular and Diving-Related Complications
- Science, Research, and Medicine
- Climate Change and Geoengineering
- Healthcare professionals’ stress and burnout
- Cardiac and Coronary Surgery Techniques
- Workplace Violence and Bullying
- Muscle Physiology and Disorders
- Pleural and Pulmonary Diseases
Columbia University Irving Medical Center
2013-2024
Columbia University
2008-2024
Center for Innovation
2024
Sanofi (United Kingdom)
2023
NewYork–Presbyterian Hospital
2020
New York Hospital Queens
2020
Over 40 000 patients with COVID-19 have been hospitalised in New York City (NY, USA) as of April 28, 2020. Data on the epidemiology, clinical course, and outcomes critically ill this setting are needed.
Abstract Background Nearly 30,000 patients with coronavirus disease-2019 (COVID-19) have been hospitalized in New York City as of April 14 th , 2020. Data on the epidemiology, clinical course, and outcomes critically ill COVID-19 this setting are needed. Methods We prospectively collected clinical, biomarker, treatment data adults laboratory-confirmed-COVID-19 admitted to two hospitals northern Manhattan between March 2 nd 1 st The primary outcome was in-hospital mortality. Secondary...
Rationale: Early mobilization of extracorporeal membrane oxygenation (ECMO)-supported patients is increasingly common, but it remains unknown whether there are factors predictive achieving higher intensity among those able to participate in physical therapy. Additionally, data regarding the safety and feasibility early with femoral cannulation, particularly ambulation, sparse. Objectives: To determine associated out-of-bed versus in-bed therapy ECMO-supported participating therapy,...
Coronavirus disease 2019 (COVID-19) emerged as a public health crisis that disrupted normal patterns of care in the New York City metropolitan area. In preparation for large influx critically ill patients, operating rooms (ORs) at NewYork-Presbyterian/Columbia University Irving Medical Center (NYP-Columbia) were converted into novel intensive unit (ICU) area, room (ORICU).Twenty-three ORs an 82-bed ORICU. Adaptations to OR environment permitted delivery standard critical therapies....
The aim of this study was to pool multiple data sets build a patient-centric, data-informed, natural history model (NHM) for Duchenne muscular dystrophy (DMD) estimate disease trajectory across patient lifetime under current standard care in future economic evaluations. conducted as part Project HERCULES, multi-stakeholder collaboration develop tools support health technology assessments new treatments DMD. Health states were informed by review NHMs DMD and input from clinicians, patients...
Hooked: Ethics, the Medical Profession, and Pharmaceutical Industry Brody H. Lanham, MD: Rowman & Littlefield Publishers, 2007. ISBN-10: 0742552187; ISBN-13: 978-0742552180. 382 pages, $29.95. “This pen will not induce you to prescribe any particular medication. Best wishes, Dr Cook” Thus read words engraved on translucent green that my attending handed me after a busy afternoon in medicine clinic. I was an eager young medical student, at time, inscription seemed clever but perhaps bit...
Abstract Background No clear guidelines exist for perioperative anticoagulation management after durable left ventricular assist device insertion. In this study, we sought to compare outcomes between anti‐factor Xa (FXa) and activated partial thromboplastin time (aPTT) in monitoring unfractionated heparin (UFH) dosing HeartMate 3 (HM3) Methods This is a single‐center retrospective review of patients who received UFH HM3 insertion 01/2020–12/2022. Post‐operative dose was titrated by aPTT goal...
Introduction No clear guidelines exist for unfractionated heparin (UFH) monitoring in adult patients on veno-arterial extracorporeal life support (VA-ECLS) refractory cardiogenic shock. In this study, we sought to compare outcomes between anti-factor Xa (FXa) and activated partial thromboplastin time (aPTT) strategies UFH during VA-ECLS. Methods This is a single-center, retrospective review of VA-ECLS who received the cardiothoracic intensive care unit July 2019 November 2023. Standard...